Protocol No
DAIICHI-SANKYO-DS3201-343
Staff Member
Deepak Kilari
Phase
I
Summary
This project is being done to investigate whether valemetostat tosylate (hereafter referred to as valemetostat), given in combination with darolutamide is safe and effective for treating prostate cancer that no longer responds to hormone therapy treatment.
Objective
Phase 1 Trial of Valemetostat and Darolutamide in mCRPC
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov